Page last updated: 2024-10-19

niacinamide and Asthenia

niacinamide has been researched along with Asthenia in 10 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.

Research Excerpts

ExcerptRelevanceReference
"Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC)."7.83[Implementation of a nurse-driven educational program improves management of sorafenib's toxicities in hepatocellular carcinoma]. ( Boucher, E; Brunot, A; Crouzet, L; Duval, M; Edeline, J; Guillygomarc'h, A; Laguerre, B; Le Roy, F; Le Sourd, S; Lelievre, N; M'Sadek, A; Ventroux, E, 2016)
"Sorafenib is the standard of care for advanced hepatocellular carcinoma (HCC)."7.81Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors. ( Boucher, E; Brunot, A; Cattenoz, C; Crouzet, L; Edeline, J; Gédouin, D; Guillygomarc'h, A; Larible, C; Latournerie, M; Le Roy, F; Le Sourd, S, 2015)
"Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC)."3.83[Implementation of a nurse-driven educational program improves management of sorafenib's toxicities in hepatocellular carcinoma]. ( Boucher, E; Brunot, A; Crouzet, L; Duval, M; Edeline, J; Guillygomarc'h, A; Laguerre, B; Le Roy, F; Le Sourd, S; Lelievre, N; M'Sadek, A; Ventroux, E, 2016)
"Sorafenib is the standard of care for advanced hepatocellular carcinoma (HCC)."3.81Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors. ( Boucher, E; Brunot, A; Cattenoz, C; Crouzet, L; Edeline, J; Gédouin, D; Guillygomarc'h, A; Larible, C; Latournerie, M; Le Roy, F; Le Sourd, S, 2015)
"One hundred patients with sleep disorders and asthenic syndrome of various etiology and severity were studied."2.90[Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome]. ( Esipov, AV; Ivolgin, AF; Kalyagin, IE; Karakozov, AG; Katenko, SV; Kazakov, SP; Khritinin, DF; Levchenko, OB; Molodova, AI, 2019)
"Angiogenesis does not initiate malignancy but promotes tumor progression and metastasis."2.44[Oral drugs inhibiting the VEGF pathway]. ( Armand, JP; Mir, O; Ropert, S, 2007)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Esipov, AV1
Ivolgin, AF1
Khritinin, DF1
Katenko, SV1
Kazakov, SP1
Karakozov, AG1
Kalyagin, IE1
Levchenko, OB1
Molodova, AI1
Castellano, D1
Capdevila, J1
Sastre, J1
Alonso, V1
Llanos, M1
García-Carbonero, R1
Manzano Mozo, JL1
Sevilla, I1
Durán, I1
Salazar, R1
Derbel Miled, O1
Dionne, C1
Terret, C1
Segura-Ferlay, C1
Flechon, A1
Neidhart, EM1
Negrier, S1
Droz, JP1
Polunina, AG1
Osinovskaia, NA1
Gudkova, AN1
Gekht, AB1
Edeline, J2
Crouzet, L2
Le Sourd, S2
Larible, C1
Brunot, A2
Le Roy, F2
Cattenoz, C1
Latournerie, M1
Gédouin, D1
Guillygomarc'h, A2
Boucher, E2
M'Sadek, A1
Duval, M1
Ventroux, E1
Lelievre, N1
Laguerre, B1
Suslina, ZA1
Klocheva, EG1
Piradov, MA1
Rumiantseva, SA1
Romantsov, MG1
Kovalenko, AL1
Ropert, S1
Mir, O1
Armand, JP1
Pietranera, P1
Chouinard, C1

Reviews

1 review available for niacinamide and Asthenia

ArticleYear
[Oral drugs inhibiting the VEGF pathway].
    Bulletin du cancer, 2007, Volume: 94 Spec No

    Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Asthenia; Axitinib; Benzenesulfonates; Human

2007

Trials

2 trials available for niacinamide and Asthenia

ArticleYear
[Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2019, Volume: 119, Issue:9

    Topics: Administration, Oral; Antioxidants; Asthenia; Drug Combinations; Flavin Mononucleotide; Humans; Inos

2019
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801).
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:18

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asth

2013

Other Studies

7 other studies available for niacinamide and Asthenia

ArticleYear
Sorafenib and sunitinib for elderly patients with renal cell carcinoma.
    Journal of geriatric oncology, 2013, Volume: 4, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Asthenia; Carcinoma, Renal Cell; Disease-Free Surviv

2013
[Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:2

    Topics: Adult; Asthenia; Autonomic Nervous System; Drug Combinations; Emotions; Female; Flavin Mononucleotid

2014
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors.
    Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:1

    Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Agents; Asthenia; Carcinoma, Hepatocellular; Comorbid

2015
[Implementation of a nurse-driven educational program improves management of sorafenib's toxicities in hepatocellular carcinoma].
    Bulletin du cancer, 2016, Volume: 103, Issue:11

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Asthenia; Carcinoma, Hepatocellular; Diarrhea; Fe

2016
[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia].
    Klinicheskaia meditsina, 2010, Volume: 88, Issue:3

    Topics: Asthenia; Brain Ischemia; Chronic Disease; Drug Combinations; Flavin Mononucleotide; Humans; Inosine

2010
[Therapeutic value of an association of phospholipids and adrenal cortex in hepatology].
    La Clinica terapeutica, 1971, Mar-31, Volume: 56, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adult; Aged; Asthenia; Biliary Tract Diseases;

1971
[Asthenia in children].
    La Vie medicale au Canada francais, 1973, Volume: 2, Issue:5

    Topics: Adolescent; Asthenia; Child; Child, Preschool; Fructosephosphates; Humans; Lysine; Niacinamide; Pare

1973